Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 2, 2002 - Issue 3
Submit an article Journal homepage
28
Views
18
CrossRef citations to date
0
Altmetric
Perspective

AntiCD20 mAbs: modifying therapeutic strategies and outcomes in the treatment of lymphoma patients

Antonio J Grillo-López Neoplastic and Autoimmune Diseases, Research Institute, PO Box 3797, Rancho Santa Fe, CA 92067, USA. [email protected]
Pages 323-329 | Published online: 10 Jan 2014

Citations (18)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Gerhard Held, Viola Pöschel & Michael Pfreundschuh. (2006) Rituximab for the treatment of diffuse large B-cell lymphomas. Expert Review of Anticancer Therapy 6:8, pages 1175-1186.
Read now

Articles from other publishers (17)

Jeffrey S. Ross. 2013. Genomic and Personalized Medicine. Genomic and Personalized Medicine 798 819 .
Jeffrey S. Ross. 2010. Essentials of Genomic and Personalized Medicine. Essentials of Genomic and Personalized Medicine 532 547 .
Michela Cesco-Gaspere, Emma Morris & Hans J. Stauss. (2009) Immunomodulation in the treatment of haematological malignancies. Clinical and Experimental Medicine 9:2, pages 81-92.
Crossref
Jeffrey S. Ross. 2009. Genomic and Personalized Medicine. Genomic and Personalized Medicine 990 1007 .
Jeffrey S. Ross. 2008. Pharmacogenomics and Personalized Medicine. Pharmacogenomics and Personalized Medicine 267 298 .
Tomonori Tawara, Kazumasa Hasegawa, Yusuke Sugiura, Tomoyuki Tahara, Isao Ishida & Shiro Kataoka. (2007) Fully human antibody exhibits pan-human leukocyte antigen-DR recognition and high in vitro/vivo efficacy against human leukocyte antigen-DR-positive lymphomas. Cancer Science 98:6, pages 921-928.
Crossref
A R Abbas, D Baldwin, Y Ma, W Ouyang, A Gurney, F Martin, S Fong, M van Lookeren Campagne, P Godowski, P M Williams, A C Chan & H F Clark. (2005) Immune response in silico (IRIS): immune-specific genes identified from a compendium of microarray expression data. Genes & Immunity 6:4, pages 319-331.
Crossref
Philip Kuriakose. (2017) Targeted Therapy for Hematologic Malignancies. Cancer Control 12:2, pages 82-90.
Crossref
Antonio J. Grillo-López. (2005) 90Y-ibritumomab tiuxetan: Rationale for patient selection in the treatment of indolent non-Hodgkin’s lymphoma. Seminars in Oncology 32, pages 44-49.
Crossref
Bruce D Cheson. (2005) The Role of Radioimmunotherapy with Yttrium-90 Ibritumomab Tiuxetan in the Treatment of Non-Hodgkin Lymphoma. BioDrugs 19:5, pages 309-322.
Crossref
Myron S. Czuczman, Robin Weaver, Baha Alkuzweny, Judy Berlfein & Antonio J. Grillo-López. (2004) Prolonged Clinical and Molecular Remission in Patients With Low-Grade or Follicular Non-Hodgkin's Lymphoma Treated With Rituximab Plus CHOP Chemotherapy: 9-Year Follow-Up. Journal of Clinical Oncology 22:23, pages 4711-4716.
Crossref
Jeffrey S. Ross, David P. Schenkein, Robert Pietrusko, Mark Rolfe, Gerald P. Linette, James Stec, Nancy E. Stagliano, Geoffrey S. Ginsburg, W. Fraser Symmans, Lajos Pusztai & Gabriel N. Hortobagyi. (2004) Targeted Therapies for Cancer 2004. American Journal of Clinical Pathology 122:4, pages 598-609.
Crossref
Sophie Song & Faramarz Naeim. 2004. Cancer Diagnostics. Cancer Diagnostics 199 232 .
Neus Villamor, Emili Montserrat & Dolors Colomer. (2003) Mechanism of action and resistance to monoclonal antibody therapy. Seminars in Oncology 30:4, pages 424-433.
Crossref
Timothy M Fan. (2003) Lymphoma updates. Veterinary Clinics of North America: Small Animal Practice 33:3, pages 455-471.
Crossref
Jeffrey S. Ross, Karen Gray, Gary S. Gray, Peter J. Worland & Mark Rolfe. (2003) Anticancer Antibodies. American Journal of Clinical Pathology 119:4, pages 472-485.
Crossref
Robert P. NelsonJrJr & Mark Ballow. (2003) 26. Immunomodulation and immunotherapy: Drugs, cytokines, cytokine receptors, and antibodies. Journal of Allergy and Clinical Immunology 111:2, pages S720-S732.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.